Androdias, Géraldine; Lünemann, Jan D.; Maillart, Elisabeth; Amato, Maria Pia; Audoin, Bertrand; Bruijstens, Arlette L.; Bsteh, Gabriel; Butzkueven, Helmut; Ciccarelli, Olga; Cobo-Calvo, Alvaro; Derfuss, Tobias; Di Pauli, Franziska; Edan, Gilles; Enzinger, Christian; Geraldes, Ruth; Granziera, Cristina; Hacohen, Yael; Hartung, Hans Peter; Hynes, Sinéad; Inglese, Matilde; Kappos, Ludwig; Kuusisto, Hanna; Langer-Gould, Annette; Magyari, Melinda; Marignier, Romain; Montalban, Xavier; Mycko, Marcin P.; Nourbakhsh, Bardia; Oh, Jiwon; Oreja-Guevara, Celia; Piehl, Fredrik; Prosperini, Luca; Sastre-Garriga, Jaume; Sellebjerg, Finn; Selmaj, Krzysztof; Siva, Aksel; Tallantyre, Emma; van Pesch, Vincent; Vukusic, Sandra; Weinstock-Guttman, Bianca; Zipp, Frauke; Tintoré, Mar; Iacobaeus, Ellen; Stankoff, Bruno (05 / 2025)
reviewarticle
The development of disease-modifying therapies (DMTs) for the treatment of multiple sclerosis (MS) has been highly successful in recent decades. It is now widely accepted that early initiation of DMTs after disease onset ...
